Description: Piramal Enterprises Limited produces and sells pharmaceutical, medicinal, and chemical and botanical products in India and internationally. It operates through Pharmaceuticals Manufacturing and Services, and Financial Services segments. The company offers contract development and manufacturing solutions across the drug life cycle, including drug discovery, clinical development, and commercial manufacturing of active pharmaceutical ingredients (API) and formulations. It also provides inhalation anaesthetics, including Sevoflurane, Isoflurane, and Halothane; Intrathecal Baclofen therapy for spasticity management; injectable anaesthesia/pain management products; and API generics, vitamins and nutritions, and premixes. In addition, the company offers over-the-counter products for skin care, pain management, oral care, respiratory, gastro-intestinal, women's health, and baby care and kids wellbeing primarily under the Saridon, Lacto Calamine, I-Pill, Supradyn, Polycrol, and Tetmosol brands. Further, it provides PhytoMedicines products to manage lifestyle ailments, such as cough-cold, women-care range, stress relievers, sleep disorders, piles, skin care-topicals, immunity enhancer, liver disorder, and others. Additionally, the company offers a suite of financial products to various real estate developers and under special situation opportunities in various sectors; and engages in investment activities. Piramal Enterprises Limited has strategic alliances with APG Asset Management, Bain Capital Credit, CPPIB Credit Investment Inc., and Ivanhoé Cambridge. The company was formerly known as Piramal Healthcare Limited and changed its name to Piramal Enterprises Limited in July 2012. Piramal Enterprises Limited was incorporated in 1947 and is based in Mumbai, India.
Home Page: www.piramal.com
Officers
| Name | Title |
|---|---|
| Mr. Ajay Gopikisan Piramal | Exec. Chairman |
| Dr. Swati Ajay Piramal | Vice Chairperson |
| Mr. Vivek Valsaraj | Pres & CFO |
| Mr. Bipin Singh | Company Sec. & Compliance Officer |
| Ms. Nandini A. Piramal | Exec. Director |
Exchange: BSE
Country: IN
Currency: Indian Rupee (INR)
| Forward PE: | 149.2537 |
|---|---|
| Trailing PE: | 257.9193 |
| Price-to-Book MRQ: | 0.7353 |
| Price-to-Sales TTM: | 1.3799 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 6579 |